107 results on '"Schwartz, Marc"'
Search Results
2. Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease
3. Squamous cell carcinoma of the scalp causing cortical venous thrombosis and Intraparenchymal hematoma
4. Tu1645 DIFFERENTIAL PATTERNS AND BENEFIT OF IBS-D MEDICATION USE IN SURGICALLY NAIVE PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS.
5. Mo1832 PERIPHERAL BLOOD MONOCYTOSIS IS ASSOCIATED WITH INCREASED RISK OF INITIAL BIOLOGIC TREATMENT FAILURE IN IBD.
6. Mo1824 CONCOMITANT VASCULITIS AND INFLAMMATORY BOWEL DISEASE DEFINES A RARE, SEVERE DISEASE SUBGROUP WITH HIGH BIOLOGIC REQUIREMENT.
7. Mo1778 LOW SERUM LIPASE IS A BIOMARKER OF IMPENDING HOSPITALIZATION IN IBD: ASSOCIATION WITH MALNUTRITION AND CLINICAL INFLAMMATORY SEVERITY.
8. Sa1939 APPLYING THE GLIM CRITERIA TO IDENTIFY IBD PATIENTS AT RISK FOR MALNUTRITION USING THE ELECTRONIC MEDICAL RECORD: A PRAGMATIC POPULATION HEALTH FEASIBILITY PILOT STUDY.
9. 550 INTESTINAL ANASTOMOSIS TYPE IMPACTS 5 YEAR POST-OPERATIVE QUALITY OF LIFE AND NEED FOR REPEAT SURGERY IN CROHN'S DISEASE: A REAL WORLD COMPARATIVE EFFECTIVENESS STUDY.
10. Patient Persistence to OnabotulinumtoxinA Treatment for Overactive Bladder Using A Reduced-Injection-Site Paradigm: A Retrospective Chart Review Study.
11. Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort Study.
12. Neuroscience knowledge enriches pedagogical choices.
13. Mo1808 THE EFFECTS OF ILEOCECAL RESECTION ON FECAL MICROBIOME DIVERSITY AND COMPOSITION ARE NOT SIGNIFICANTLY ALTERED BY BILE ACID SEQUESTRANTS IN PATIENTS WITH CROHN'S DISEASE.
14. Sa1821 PREVALENCE AND RISK FACTORS OF EXOCRINE PANCREATIC INSUFFICIENCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
15. Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
16. Correlation of anemia status with worsening bowel damage as measured by Lémann Index in patients with Crohn's disease.
17. Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease.
18. OnabotulinumtoxinA Treatment in Patients with Upper Limb and Lower Limb Spasticity from the ASPIRE Study.
19. Mo1538: BASELINE PERIPHERAL BLOOD EOSINOPHILIA PREDICTS DECREASED RESPONSE TO INITIAL ANTI-TNF BIOLOGIC THERAPY IN IBD.
20. Mo1478: PARASTOMAL PYODERMA GANGRENOSUM IN IBD: PREVALENCE, TREATMENT, AND CLINICAL OUTCOMES IN A TERTIARY CENTER.
21. Sa1587: GRANULOMA PRESENCE AT INITIAL SURGERY PREDICTS NEED FOR REPEAT SURGERY INDEPENDENT OF RUTGEERTS' ENDOSCOPIC SCORE IN CROHN'S DISEASE.
22. 1138: ULTRA-PROCESSED FOOD CONSUMPTION AND MULTIYEAR CLINICAL TRAJECTORIES IN IBD.
23. Transapical Mitral Implantation of the Tiara Bioprosthesis: Pre-Clinical Results.
24. Sustained efficacy and tolerability of onabotulinumtoxinA in naive and non-naive patients with cervical dystonia: Preliminary completer analysis from CD-PROBE.
25. Auditory Brainstem Implants
26. P019 OPTIMIZING NUTRITION RISK SCREENING AND FOLLOW-UP NUTRITION COUNSELING IN AN OUTPATIENT INFLAMMATORY BOWEL DISEASE POPULATION.
27. Su524 PERIPHERAL BLOOD MONOCYTOSIS IS A NOVEL BIOMARKER OF LONG-TERM DISEASE SEVERITY IN PEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE.
28. Su515 THE ASSOCIATION OF ORAL VANCOMYCIN ADMINISTRATION AND FAECAL MICROBIOME COMPOSITION IN PATIENTS WITH CROHN'S DISEASE.
29. Su507 INCREASED HOSPITAL ADMISSIONS ARE ASSOCIATED WITH DECREASED GUT MICROBIOME DIVERSITY AND DECREASED FAECALOBACTERIUM IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY.
30. Sa487 DERMATOLOGIC MANIFESTATIONS OF IBD: ASSOCIATION WITH NATURAL HISTORY AND BIOMARKERS OF SEVERITY.
31. 249 POSITIVE GLUTEN SENSITIVITY SEROLOGIES AND THE IMPACT OF GLUTEN FREE DIET IN PATIENTS WITH IBD.
32. Mo1654 CHARACTERIZING THE COLONOSCOPIC FEATURES OF CLOSTRIDIUM DIFFICILE INFECTION IN INFLAMMATORY BOWEL DISEASE.
33. 45. Exploring Reproductive Health Decision Experiences and Preferences of Women With Pediatric-Onset Inflammatory Bowel Diseases.
34. Complete Resolution of Mucosal Neutrophils Associates With Improved Long-Term Clinical Outcomes of Patients With Ulcerative Colitis.
35. P006 AFTER-HOURS PATIENT PHONE CALLS TO GI FELLOWS WITHIN AN IBD MEDICAL HOME.
36. Bridging Anticoagulation.
37. Epithelioid Granulomas Associate With Increased Severity and Progression of Crohn’s Disease, Based on 6-Year Follow-Up.
38. Sa1839 - Poor Consumption of Fiber, not fat, is Associated with Active Disease in Inflammatory Bowel Disease.
39. Mo1822 - Variation in Annual Rate of Steroid Prescriptions Amongst Providers for Inflammatory Bowel Disease Patients is Dependent on Cohort Size and Disease Severity.
40. Mo1675 - Effects of Behavioral Treatment on Anxiety and Medical Utilization in Patients with IBD or FGID.
41. Sa1856 - Is High Globulin Fraction a Biomarker of Severity in Inflammatory Bowel Disease (IBD)? Analysis of a 6-Year, Prospective Natural History Registry.
42. Predictors of onabotulinumtoxina response in patients with cervical dystonia.
43. Tu1946 Can We Phenotype IBD Patients Based on Financial Charges Over Time? Trajectory Modeling of Healthcare Utilization in a Large, Prospective IBD Cohort.
44. 165 Is Monocytosis a Biomarker of Severity in Inflammatory Bowel Disease? Analysis of a 6 Year, Prospective Natural History Registry.
45. Sa1918 Weight Fluctuation in Inflammatory Bowel Disease Predicts Future Healthcare Utilization.
46. Su1810 Clostridium difficile Infection in Inflammatory Bowel Disease Predicts Future Healthcare Utilization.
47. Tu1932 Long Term Implications of Achieving and Retaining Remission in Crohn's Disease as Defined by Harvey Bradshaw Index.
48. Sa1876 Do Epithelioid Granulomas Function As a Biomarker of Severity in Crohn's Disease? Analysis of a Prospective Six-Year Natural History Registry.
49. Sa1954 Sickest of the Sick: When Anti-TNF Agents Fail to Halt Progression of Bowel Damage in Crohn's Disease Over Time.
50. 1123 Investigating the Changes in Atherosclerotic Cardiovascular Risk Profile of IBD Patients Over 6 Years.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.